Nexans invests in its Draveil site to double production capacity of medical cables

• Nexans is investing €4.5 million in its Draveil site to double production capacity of medical cables in response to growing demand.

• The NEWSENSE® micro-cables will be produced by machines entirely designed and manufactured by Nexans.

• Building on the expertise and know-how of the Draveil workforce, the Group is developing its cable offering dedicated to minimally invasive surgical technologies, pushing the limits of miniaturization.

Paris, June 25, 2024 - Nexans has announced a €4.5 million investment in its Draveil site outside Paris to double its production capacity for medical cables.

With this investment, Nexans will be able to meet growing demand for medical micro-cables used in invasive surgery, a fast-growing market expected to achieve annual growth of 5% a year over the next five years. These cables are used in particular for transcatheter technology and cardiovascular electrophysiology, as well as for monitoring sensors and endoscopy cable solutions.

Through this investment, Nexans will be able to develop its NEWSENSE range of medical cables in a new workshop expanding the existing facilities at the Draveil site. The Group is reaffirming its commitment to manufacturing in France, particularly for products requiring a high level of expertise, as it is the case in the medical field.

These cables meet the most stringent quality standards and will be manufactured on machines specially designed and built by the engineering teams at Nexans Draveil, as they seek to continuously push back the limits of miniaturization. As these machines do not yet exist on the market, they wil further sharpen the competitive edge of Nexans, allowing it to consolidate its position as an industrial leader in cutting-edge technologies.

Delivering the speed and efficiency necessary to stay competitive in this niche market, these machines also meet the highest standards of reliability and quality, with the use of optical control technology to inspect the cables on the production line.

With this investment, Nexans will be able to develop its offering for medical OEMs, a field in which the company has over 30 years' experience. With a dedicated plant and laboratory, Nexans is setting the standard in the supply of micro-cables for devices used in medical exploration as well as in diagnosis and treatment, greatly improving comfort for both healthcare professionals and patients alike.